Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:08 AM
Referred By : Self Barcode No : HY634314
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Annual Health Checkup3
Complete Blood Count (CBC)
RBC Parameters
Hemoglobin 13.6 g/dL 13.0 - 17.0
colorimetric
RBC Count 3.7 10^6/µl 4.5 - 5.5
Electrical impedance
PCV 39.7 % 40 - 50
Calculated
MCV 106.6 fl 83 - 101
Calculated
MCH 36.4 pg 27 - 32
Calculated
MCHC 34.1 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 14.6 % 11.6 - 14.0
Calculated
RDW-SD * 60.5 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 7.9 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 54 % 40-80
Lymphocytes * 34 % 20-40
Monocytes * 7 % 2-10
Eosinophils 5 % 1-6
Basophils * 0 % <2
Absolute Leukocyte Counts *
Neutrophils. * 4.27 10^3/µl 2-7
Lymphocytes. * 2.69 10^3/µl 1-3
Monocytes. * 0.55 10^3/µl 0.2 - 1.0
Eosinophils. * 0.4 10^3/µl 0.02 - 0.5
Basophils. * 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 212 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 12 fL 9.3 - 12.1
Calculated
PCT * 0.2 % 0.17 - 0.32
Calculated
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 1 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:08 AM
Referred By : Self Barcode No : HY634314
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
P-LCR * 46.9 % 18 - 50
Calculated
P-LCC * 99 % 44 - 140
Calculated
Mentzer Index * 28.81 % > 13
Calculated
Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 2 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 12:12 PM
Referred By : Self Barcode No : HY634314
Sample Type : Whole blood EDTA Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 16 mm/hr 0 - 10
MODIFIED WESTERGREN
Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.
AGE MALE FEMALE
1 DAY 0-2 0-2
2 - 7 DAYS 0-4 0-4
8 - 14 DAYS 0-17 0-17
15 DAYS - 17 YEARS 0-20 0-20
18 - 50 YEARS 0-10 0-12
51- 60 YEARS 0-12 0-19
61 - 70 YEARS 0-14 0-20
71 - 100 YEARS 0-30 0-35
Reference- Dacie and lewis practical hematology
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 3 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:46 AM
Referred By : Self Barcode No : ZC777388
Sample Type : Fluoride Plasma Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Glucose Random (BSR)
Glucose Random 87.2 mg/dL 70 - 140
(Fluoride Plasma-R,Hexokinase)
Interpretation:
[Link] known as Casual plasma glucose .
[Link] can be taken anytime during the day regardless of eating time.
[Link] blood glucose level of equal to or more than 200mg/dl is indicative of Diabetes mellitus.
Source: ADA Guidelines
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 4 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:57 AM
Referred By : Self Barcode No : ZC777387
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Liver Function Test (LFT)
Bilirubin Total 1.1 mg/dL 0 - 1.2
Colorimetric Diazo
Bilirubin Direct 0.35 mg/dL 0 - 0.20
Bilirubin Indirect * 0.75 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)
SGOT/AST 37.2 U/L up to 40
IFCC without P5P
SGPT/ALT 39 U/L up to 41
IFCC without P5P
SGOT/SGPT Ratio * 0.95 - -
Alkaline Phosphatase 125 U/L 40 - 129
IFCC
Total Protein 8.0 g/dL 6.0 - 7.8
Biuret
Albumin 4.7 g/dL 3.5 - 5.2
Colorimetric
Globulin * 3.3 g/dL 2.3 - 3.5
Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.42 - 1.0 - 2.1
Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) 31.7 U/L 5 -40
ENZYMATIC
Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood
clotting proteins, and performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical
reactions. When liver cells are damaged or destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood
tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in
muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT
and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of
the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline
phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is
by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile
flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all
cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood contains two classes of protein, albumin and
globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your immune system. Low
total protein may
Indicate:
[Link]
[Link] disorder
[Link]
[Link] High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive
water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low
albumin levels may be
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 5 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:57 AM
Referred By : Self Barcode No : ZC777387
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Caused by:
1.A poor diet (malnutrition).
[Link] disease.
[Link] disease. High albumin levels may be caused by: Severe dehydration.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 6 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:57 AM
Referred By : Self Barcode No : ZC777387
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Kidney Function Test (KFT)
Blood Urea 24.2 mg/dL 16.6 - 48.5
Urease
Creatinine 0.7 mg/dL 0.70 - 1.20
Jaffe
Bun * 11.31 mg/dL 6 - 20
Urease
Bun/Creatinine Ratio * 16.16
Urea / Creatinine Ratio * 34.57
Uric Acid 7.6 mg/dL 3.4 - 7.0
Enzymatic colorimetric
Calcium Serum 9.7 mg/dL 8.6 - 10.0
BAPTA
Phosphorus 3.3 mg/dL 2.5 - 4.5
Molybdate UV
Sodium 135.9 mmol/L 136 - 145
ISE-Indirect
Potassium 4.6 mmol/L 3.5 - 5.1
ISE-Indirect
Chloride 97.3 mmol/L 98 - 107
ISE-Indirect
Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may indicate
a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful urination,swelling
in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring simultaneously, these
symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes (sodium,potassium,and
chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells and organs. There has to
be a [Link] calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress and treatment of these
diseases.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 7 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:57 AM
Referred By : Self Barcode No : ZC777387
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
Lipid Profile
Total Cholesterol 134 mg/dL <200
Enzymatic - Cholesterol Oxidase
Triglycerides 285 mg/dL <150
Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 30 mg/dL >55
Enzymatic colorimetric
Non HDL Cholesterol * 104 mg/dL <130
Calculated
LDL Cholesterol 47 mg/dL <100
Calculated
V.L.D.L Cholesterol * 57 mg/dL < 30
Calculated
Chol/HDL Ratio * 4.47 Ratio 3.5 - 5.0
Calculated
HDL/ LDL Ratio * 0.64 Ratio 0.5 - 3.0
Calculated
LDL/HDL Ratio * 1.57 Ratio -
Calculated
Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.
National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220
HDL Cholesterol
Low High
<40 >=60
Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.
Risk Category A. CAD with > 1 feature of high risk group
B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
[Link] ASCVD [Link] with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 8 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:57 AM
Referred By : Self Barcode No : ZC777387
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors
Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors
1. Age >/=45 years in Males &
3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.
Risk Group Treatment Goals Consider Drug Therapy
LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)
Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160
* After an adequate non-pharmacological intervention for at least 3 months.
References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 9 of 10
Patient Name : Mr Arujn
DOB/Age/Gender : 22 Y/Male Sample Collected : May 14, 2024, 09:00 AM
Patient ID / UHID : 8282936/RCL7495800 Report Date : May 15, 2024, 11:10 AM
Referred By : Self Barcode No : ZC777387
Sample Type : Serum Report Status : Final Report
Test Description Value(s) Unit(s) Reference Range
TSH May Onsite
TSH 3rd Generation
Thyroid Stimulating Hormone (Ultrasensitive) 1.8 µIU/mL 0.27 - 4.20
ECLIA
Interpretation:
Pregnancy Reference ranges TSH
1 st Trimester 0.1 - 2.5
2 ed Trimester 0.2 - 3.0
3 rd Trimester 0.3 - 3.0
TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm . The variation is of
the order of 50% . hence time of the day has influence on the measured serum TSH concentrations.
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are significantly
elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome, multiple alterations
in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI) without evidence of
preexisting thyroid or hypothalami c-pitutary diseases.
Thyroid Binding Globulin (TBG) concentrations remain relatively constant in healthy individuals. However, pregnancy, excess estrogen,
androgen, antibiotics, steroids and glucocorticoids are known to alter TBG levels and may cause false thyroid values for Total T3 and T4 tests.
*** End Of Report ***
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Booking Centre :- PARK MEDICLAIM TPA PVT LTD, 702, Vikrant Tower,Rajendra Place, Delhi, 110008
Processing Lab :- Redcliffe Lifetech Pvt. Ltd., M -16 Ground Floor, Old DLF Market, Near SBI Bank, Sector 14 Gurgaon,
Pin Code-122001
Page 10 of 10
Terms and Conditions of Reporting
1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.
2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.
3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.
4. This report shall not be deemed valid or admissible for any medico-legal purposes.
5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
